Your browser doesn't support javascript.
loading
Obinutuzumab as consolidation after chemo-immunotherapy: Results of the UK National Cancer Research Institute phase II/III GALACTIC trial.
Munir, Talha; Emmerson, Jake; Hockaday, Anna; Oughton, Jamie B; Howard, Dena; Phillips, David; Neilson, Jeff; Pemberton, Nicholas; Paneesha, Shankara; Kennedy, Ben; Rawstron, Andy; Hillmen, Peter.
Afiliación
  • Munir T; St James's Institute of Oncology, St James's University Hospital, Leeds, UK.
  • Emmerson J; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Hockaday A; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Oughton JB; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Howard D; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Phillips D; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Neilson J; Russell Hall Hospital, Dudley, UK.
  • Pemberton N; Worcestershire Royal Hospital, Worcestershire, UK.
  • Paneesha S; Birmingham Heartlands Hospital, Birmingham, UK.
  • Kennedy B; Leicester Royal Infirmary, Leicester, UK.
  • Rawstron A; Haematological Malignancy Diagnostic Service, St James's Institute of Oncology, St James's University Hospital, Leeds, UK.
  • Hillmen P; St James's Institute of Oncology, St James's University Hospital, Leeds, UK.
Br J Haematol ; 199(5): 707-719, 2022 12.
Article en En | MEDLINE | ID: mdl-36017875

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido